AEPFX | FCADX | AEPFX / FCADX | |
Total Expense Ratio | 0.58 | 1.62 | 36% |
Annual Report Gross Expense Ratio | 0.58 | 1.62 | 36% |
Fund Existence | 17 years | 21 years | - |
Gain YTD | 22.199 | 26.481 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 139B | 11.8B | 1,178% |
Annual Yield % from dividends | 0.82 | 1.49 | 55% |
Returns for 1 year | 11.13 | 20.10 | 55% |
Returns for 3 years | 54.39 | 75.73 | 72% |
Returns for 5 years | 16.25 | 27.35 | 59% |
Returns for 10 years | 51.71 | 58.96 | 88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GMAY | 40.59 | 0.01 | +0.01% |
FT Vest U.S. Eq Mod Buffr ETF - May | |||
GBXC | 26.64 | N/A | N/A |
Goldman Sachs U.S. Lg Cp Buffr 3 ETF | |||
BMED | 27.79 | -0.10 | -0.37% |
iShares Health Innovation Active ETF | |||
GLOV | 56.64 | -0.22 | -0.39% |
Goldman Sachs ActBt Wld Lw Vl Ps Eq ETF | |||
PXE | 29.03 | -0.60 | -2.03% |
Invesco Energy Exploration & Prod ETF |